BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Mallinckrodt
US Department of Justice
McKesson
Julphar
Dow
Healthtrust
US Army
Merck

Generated: January 19, 2018

DrugPatentWatch Database Preview

DAUNORUBICIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Daunorubicin Hydrochloride, and what generic alternatives are available?

Daunorubicin Hydrochloride is a drug marketed by Fresenius Kabi Usa, Teva Parenteral, Teva Pharms Usa, and West-ward Pharms Int. and is included in five NDAs.

The generic ingredient in DAUNORUBICIN HYDROCHLORIDE is daunorubicin hydrochloride. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the daunorubicin hydrochloride profile page.
Drug patent expirations by year for DAUNORUBICIN HYDROCHLORIDE
Pharmacology for DAUNORUBICIN HYDROCHLORIDE

US Patents and Regulatory Information for DAUNORUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065034-001 Nov 20, 2001 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Parenteral DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 064212-002 May 3, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065000-001 May 25, 1999 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Parenteral DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 064212-001 Jun 23, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 050731-001 Jan 30, 1998 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065035-001 Jan 24, 2000 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fuji
Johnson and Johnson
Baxter
Boehringer Ingelheim
Harvard Business School
Chinese Patent Office
Queensland Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot